Saudi Chemical Holding Company

SASE:2230 Stock Report

Market Cap: ر.س7.9b

Saudi Chemical Holding Past Earnings Performance

Past criteria checks 5/6

Saudi Chemical Holding has been growing earnings at an average annual rate of 39.4%, while the Healthcare industry saw earnings growing at 20.3% annually. Revenues have been growing at an average rate of 13.8% per year. Saudi Chemical Holding's return on equity is 16%, and it has net margins of 5.4%.

Key information

39.4%

Earnings growth rate

39.4%

EPS growth rate

Healthcare Industry Growth12.3%
Revenue growth rate13.8%
Return on equity16.0%
Net Margin5.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Not Many Are Piling Into Saudi Chemical Holding Company (TADAWUL:2230) Just Yet

Dec 04
Not Many Are Piling Into Saudi Chemical Holding Company (TADAWUL:2230) Just Yet

Here's Why Saudi Chemical Holding (TADAWUL:2230) Has Caught The Eye Of Investors

Oct 24
Here's Why Saudi Chemical Holding (TADAWUL:2230) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Sep 09
There's Been No Shortage Of Growth Recently For Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Saudi Chemical Holding Company's (TADAWUL:2230) P/E Is On The Mark

May 28
Saudi Chemical Holding Company's (TADAWUL:2230) P/E Is On The Mark

Investors Met With Slowing Returns on Capital At Saudi Chemical Holding (TADAWUL:2230)

May 07
Investors Met With Slowing Returns on Capital At Saudi Chemical Holding (TADAWUL:2230)

With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case

Mar 06
With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case

Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors

Feb 10
Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors

Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return

Oct 31
Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return

Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today

Jul 06
Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today

Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50

Jan 09
Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50

Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50

Dec 22
Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50

Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Sep 14
Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around

Dec 06
Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around

Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?

Apr 19
Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?

Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital

Mar 29
Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital

Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?

Mar 01
Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?

Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?

Feb 01
Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?

How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?

Dec 28
How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?

Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?

Nov 30
Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?

Revenue & Expenses Breakdown

How Saudi Chemical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SASE:2230 Revenue, expenses and earnings (SAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,0223263640
30 Jun 245,8692883700
31 Mar 245,4602423680
31 Dec 234,8551833560
30 Sep 234,5211173530
30 Jun 234,081933360
31 Mar 233,831803220
31 Dec 223,696803100
30 Sep 223,378512950
30 Jun 223,402482850
31 Mar 223,346612920
31 Dec 213,411702900
30 Sep 213,491532640
30 Jun 213,517642700
31 Mar 213,476772590
31 Dec 203,306742670
30 Sep 203,066463280
30 Jun 202,991413400
31 Mar 202,909323420
31 Dec 192,949333340
30 Sep 193,2261013010
30 Jun 193,1201012800
31 Mar 192,998982630
31 Dec 182,9491152450
30 Sep 182,7681282200
30 Jun 182,6501432110
31 Mar 182,5411432090
31 Dec 172,4741422110
30 Sep 172,2741291960
30 Jun 172,2061191960
31 Mar 172,2791381970
31 Dec 162,1431341940
30 Sep 162,2581682120
30 Jun 162,3031852100
31 Mar 162,3202162100
31 Dec 152,4102512070
30 Sep 152,4132661900
30 Jun 152,4522701960
31 Mar 152,4702791870
31 Dec 142,4842841860
30 Sep 142,5662921890
30 Jun 142,4503131720
31 Mar 142,3593031690
31 Dec 132,2753011630

Quality Earnings: 2230 has high quality earnings.

Growing Profit Margin: 2230's current net profit margins (5.4%) are higher than last year (2.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2230's earnings have grown significantly by 39.4% per year over the past 5 years.

Accelerating Growth: 2230's earnings growth over the past year (178.1%) exceeds its 5-year average (39.4% per year).

Earnings vs Industry: 2230 earnings growth over the past year (178.1%) exceeded the Healthcare industry 13.5%.


Return on Equity

High ROE: 2230's Return on Equity (16%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 20:44
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Saudi Chemical Holding Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution